Literature DB >> 21944519

Impact of pancreatic cancer and subsequent resection on glycemic control in diabetic and nondiabetic patients.

Michael A White1, Steven C Agle, Hannah M Fuhr, James H Mehaffey, Brett H Waibel, Emmanuel E Zervos.   

Abstract

The incidence of new onset or worsening diabetes is surprisingly low in patients after partial pancreatectomy for cancer, leading us to question what factors predict diminished glycemic control in those undergoing resection. All patients undergoing pancreatectomy for cancer at a large, rural university teaching hospital between 1996 and 2010 were identified. The incidence of new onset, or worsening, existing diabetes was determined based on pre and postoperative medication requirement. Univariate analysis was undertaken to identify factors that predict worsened glycemic control. One hundred and one (1 total, 79 Whipple, 21 distal) patients were identified, 41 per cent of which had preexisting diabetes. Nearly half of existing diabetics manifested an increased medication requirement prior to their cancer diagnosis. New onset diabetes occurred in 20 per cent of postoperative patients. Of established diabetics, 34 per cent had either improved glycemic control (9/41) or were cured (5/41) despite the reduction of islet cell mass that occurred with surgery. On univariate analysis, only prolonged hospitalization was associated with worsened glycemic control. Diminished glycemic control is a frequent presenting symptom of pancreatic cancer. Worsened or new onset diabetes is associated with length of stay, which can be influenced by a number of factors including complications and comorbidities.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21944519

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  7 in total

1.  Long-Term Endocrine and Exocrine Insufficiency After Pancreatectomy.

Authors:  Jiro Kusakabe; Blaire Anderson; Jingxia Liu; Gregory A Williams; William C Chapman; Majella M B Doyle; Adeel S Khan; Dominic E Sanford; Chet W Hammill; Steven M Strasberg; William G Hawkins; Ryan C Fields
Journal:  J Gastrointest Surg       Date:  2019-01-22       Impact factor: 3.452

2.  Clinical outcomes of pancreaticoduodenectomy for pancreatic ductal adenocarcinoma depending on preservation or resection of pylorus.

Authors:  Yeon Jin Kim; Sang Hyun Shin; In Woong Han; Youngju Ryu; Naru Kim; Dong Wook Choi; Jin Seok Heo
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2020-08-31

3.  Predictive factors for change of diabetes mellitus status after pancreatectomy in preoperative diabetic and nondiabetic patients.

Authors:  Keiichiro Hirata; Bunzo Nakata; Ryosuke Amano; Sadaaki Yamazoe; Kenjiro Kimura; Kosei Hirakawa
Journal:  J Gastrointest Surg       Date:  2014-07-08       Impact factor: 3.452

Review 4.  Diabetes, pancreatic cancer, and metformin therapy.

Authors:  Jun Gong; Lori A Robbins; Aurelia Lugea; Richard T Waldron; Christie Y Jeon; Stephen J Pandol
Journal:  Front Physiol       Date:  2014-11-07       Impact factor: 4.566

5.  Impact Factors for Perioperative Morbidity and Mortality and Repercussion of Perioperative Morbidity and Long-term Survival in Pancreatic Head Resection.

Authors:  Stojan Potrc; Arpad Ivanecz; Vid Pivec; Urska Marolt; Sasa Rudolf; Bojan Iljevec; Tomaz Jagric
Journal:  Radiol Oncol       Date:  2017-09-14       Impact factor: 2.991

6.  Combination therapy of glucagon-like peptide-1 receptor agonists and insulin for patients who developed diabetes after partial pancreatectomy.

Authors:  Toru Kitazawa; Kazuhito Yokoyama; Ken Kubota
Journal:  J Diabetes Investig       Date:  2015-10-14       Impact factor: 4.232

7.  Investigation of the influence of pancreatic surgery on new-onset and persistent diabetes mellitus.

Authors:  Daisaku Yamada; Hidenori Takahashi; Kei Asukai; Shinichiro Hasegawa; Hiroshi Wada; Chu Matsuda; Masayoshi Yasui; Takeshi Omori; Hiroshi Miyata; Masato Sakon
Journal:  Ann Gastroenterol Surg       Date:  2021-02-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.